Gene · 5928
Papers2,308
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,308
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Clinical Implication of Conversion Surgery in Patients with Stage IV Gastric Cancer Who Received Systemic Chemotherapy. | Biomedicines | 2023 | 38002099 | PubTator, text mining | PubMed |
| The Contribution of Mediastinal Transbronchial Nodal Cryobiopsy to Morpho-Histological and Molecular Diagnosis. | Diagnostics (Basel) | 2023 | 37998611 | PubTator, text mining | PubMed |
| Use of Farnesyl Transferase Inhibitors in an Ageing Model in Drosophila. | J Dev Biol | 2023 | 37987370 | PubTator, text mining | PubMed |
| HDAC activity is dispensable for repression of cell-cycle genes by DREAM and E2F:RB complexes. | bioRxiv | 2023 | 37961464 | PubTator, text mining | PubMed |
| Targeting Liver Metastases to Potentiate Immunotherapy in MS-Stable Colorectal Cancer-A Review of the Literature. | Cancers (Basel) | 2023 | 37958384 | PubTator, text mining | PubMed |
| POLE3 is a repressor of unintegrated HIV-1 DNA required for efficient virus integration and escape from innate immune sensing. | Sci Adv | 2023 | 37922361 | PubTator, text mining | PubMed |
| FTO plays a crucial role in gastrointestinal cancer and may be a target for immunotherapy: an updated review. | Front Oncol | 2023 | 37916161 | PubTator, text mining | PubMed |
| Exploring the therapeutic potential of targeting polycomb repressive complex 2 in lung cancer. | Front Oncol | 2023 | 37909018 | PubTator, text mining | PubMed |
| The important role of miR-1-3p in cancers. | J Transl Med | 2023 | 37907984 | PubTator, text mining | PubMed |
| Treatment Patterns and Outcomes Among Patients With Advanced or Recurrent Endometrial Cancer Initiating First-Line Therapy in the United States. | J Health Econ Outcomes Res | 2023 | 37905183 | PubTator, text mining | PubMed |
| Cystoid Macular Edema following Treatment with Nanoparticle Albumin-Bound Paclitaxel and Atezolizumab for Metastatic Breast Cancer. | Case Rep Oncol | 2023 | 37900858 | PubTator, text mining | PubMed |
| Long-Term 5-Year Response to Pembrolizumab, Bevacizumab, and Capecitabine Regimen in a Metastatic Colon Cancer Patient with MSI-High and KRAS Mutation: Case Report. | Case Rep Oncol | 2023 | 37900837 | PubTator, text mining | PubMed |
| Insights from the protein interaction Universe of the multifunctional "Goldilocks" kinase DYRK1A. | Front Cell Dev Biol | 2023 | 37900285 | PubTator, text mining | PubMed |
| Data-Independent Acquisition Mass Spectrometry Analysis of FFPE Rectal Cancer Samples Offers In-Depth Proteomics Characterization of the Response to Neoadjuvant Chemoradiotherapy. | Int J Mol Sci | 2023 | 37895091 | PubTator, text mining | PubMed |
| Chromatin: the old and young of it. | Front Mol Biosci | 2023 | 37877123 | PubTator, text mining | PubMed |
| Identification of ONECUT3 as a stemness-related transcription factor regulating NK cell-mediated immune evasion in pancreatic cancer. | Sci Rep | 2023 | 37875589 | PubTator, text mining | PubMed |
| Activation of automethylated PRC2 by dimerization on chromatin. | bioRxiv | 2023 | 37873121 | PubTator, text mining | PubMed |
| DNA elements tether canonical Polycomb Repressive Complex 1 to human genes. | Nucleic Acids Res | 2023 | 37855680 | PubTator, text mining | PubMed |
| Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer. | Mol Cancer | 2023 | 37853437 | PubTator, text mining | PubMed |
| Deciphering the Mysterious Relationship between the Cross-Pathogenetic Mechanisms of Neurodegenerative and Oncological Diseases. | Int J Mol Sci | 2023 | 37834214 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5928/papers?page=14